GMP Facility
The facility was jointly funded by ¹û¶³Ó°Ôº and the ¹û¶³Ó°Ôº Hospitals Biomedical Research Centre. The state-of-the-art unit was established in 2016, and licensed by the MHRA in 2017 (Specials’ and Investigational Medicinal Products). We specialize in the manufacture of radiotracers with short-lived nuclides as well as bespoke diagnostic agents for cutting-edge imaging techniques, including hyperpolarised magnetic resonance imaging (MRI). The facility supports translational experimental medicine studies across ¹û¶³Ó°Ôº, ¹û¶³Ó°Ôº Hospitals and a number of collaborating institutions in South East England.